Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Treatment
46 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Clinical Trials
The Bristol Myers Squibb Foundation and National Medical Fellowships Launch $100 Million Program to Help Increase Diversity and Inclusion in Clinical Trials
PR-M11-20-015
FDA
FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus
PR-M03-20-NI-032
FDA Acceptance
Averitas Pharma Announces FDA Acceptance for Neuropathic Pain Treatment
PR-M12-19-NI-032
CRISPR
Startup Navega Therapeutics Aims to Develop a CRISPR Treatment for Pain
PAO-M09-19-NI-008
CRISPR
Using CRISPR to Treat Muscular Dystrophy
PAO-M08-19-NI-021
Oncology
Roche Receives CHMP Positive Opinion for New Tecentriq-based Combination Therapy as an Initial Treatment for Most Common Form of Advanced Lung Cancer
PR-M08-19-NI-004
Oncology
New Approach to Treating Pancreatic Cancer Being Explored
PAO-M07-19-NI-023
Research
New Treatment Approach for Pancreatic Cancer
PAO-M07-19-NI-023
Drug Approval
FDA Expands Approval of Treatment for Cystic Fibrosis to Include Patients Ages 6 and Older
PR-M06-19-NI-056
FDA Review
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
PR-M06-19-NI-045
FDA Approval
FDA Approves New Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women
PR-M06-19-NI-044
Drug Delivery
Drug Delivery Tech Based on Sea Lamprey Immune System Could Facilitate Treatment of Brain Disorders
PAO-M05-19-NI-030
Drug Development
EVENITY™ (romosozumab-aqqg) Now Available In The United States For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture
PR-M04-19-NI-054
Eczema Treatment
Tremotyx Debuts Plant Stem Cell-Based Eczema Treatment in the U.S.
PR-M04-19-NI-044
Opioid Treatment
Failed Depression Drug Could be Opioid Addiction Treatment
PAO-M04-19-NI-012
Allogeneic CAR-T
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
PR-M04-19-NI-028
Drug Development
Promising Treatment for Brain Cancer
PAO-M02-19-NI-019
Treatment
Analysis Of Medicare Claims Show Benefits Of Hyperbaric Oxygen Therapy For Diabetic Foot Ulcer Treatment
PR-M01-19-NI-091
Oncology
Radiotherapy Makes a Comeback
PAO-M11-18-NI-023
Oncology
Real-world Study Shows Sequencing of Gilotrif® Followed by Osimertinib Delivered a Combined Median Time on Treatment
PR-M10-18-NI-080
Clinical Trials
New Clinical Trial Will Evaluate Biomarkers as Predictors of Treatment Response in IBD
PAO-M10-18-NI-009
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery
FDA Approval
New Treatment Option for Migraine Suffers
PAO-M10-18-NI-005
Drug Development
Patients with Rare Leukemia Disease Will Have New Treatment Option
PAO-M09-18-NI-016
1
2
»
.svg)